In the traditional view of the immune system, macrophages are the "garbage collectors"—cells that arrive at a site of injury to engulf pathogens and clear debris. However, a growing body of research reveals that macrophages are actually the primary conductors of the regenerative orchestra. They possess a remarkable functional plasticity, allowing them to transition between a pro-inflammatory "attack" state (often labeled M1) and a pro-healing "repair" state (M2).
The central challenge in regenerative medicine is that in chronic diseases—such as diabetic ulcers, non-union bone fractures, or organ transplant rejection—the immune system becomes "stuck" in the inflammatory phase. This research direction focuses on macrophage repolarization: using biochemical, physical, and cellular cues to flip the functional switch of these cells from destruction to reconstruction.
The M1 to M2 Continuum
Rather than being static cell types, macrophages exist on a functional continuum. As Yuanhui Li and Jian‐Zhong Shao describe in Occurrences and Functions of Ly6Chi and Ly6Clo Macrophages in Health and Disease, monocyte-derived macrophages typically transition from an initial inflammatory phase (Ly6C$^{hi}$) to a restorative phase (Ly6C$^{lo}$).
When this transition is successful, macrophages stop secreting neurotoxic cytokines and start producing growth factors that promote angiogenesis and tissue remodeling. When it fails, the result is chronic inflammation and fibrosis. Research by Juan Du and Yaxing Zhao in Selective oxidative protection leads to tissue topological changes orchestrated by macrophage during ulcerative colitis shows that chronic inflammation can even trigger a "macrophage disappearance reaction," where protective resident populations are entirely replaced by inflammatory recruits, fundamentally altering the tissue's architecture.
Instructive Biomaterials as Immune Modulators
One of the most significant shifts in this field is moving from "biocompatible" materials (which the body merely tolerates) to "instructive" materials that actively direct immune behavior.
- Ionic Signaling: Researchers like Ben Wan and Dafu Chen have shown that strontium-substituted ceramics act as biochemical niches. In Building Osteogenic Microenvironments With Strontium-Substituted Calcium Phosphate Ceramics, they demonstrate that the local release of ions can orchestrate a pro-regenerative immune response, which is a prerequisite for bone integration. Similarly, Chaolun Dai and Binxin Wu utilized controlled magnesium release in Innovative wound management: creating dynamic Alg-Mg/SF hydrogels for controlled Mg2+ release in wound healing to accelerate the recovery of chronic wounds by encouraging this M1-to-M2 shift.
- Physical Cues: It isn't just chemistry that matters. Shuo Liu and Hong Liu argue in Materials‐Mediated In Situ Physical Cues for Bone Regeneration that surface topography and even mild heat can serve as "physical immunomodulators," shifting macrophages toward a healing state without the need for unstable biochemical growth factors.
The Stem Cell Secretome and Exosomes
While stem cell therapy was once thought to work by cells "replacing" damaged tissue, we now understand that their primary power lies in their "secretome"—the cocktail of signals they release.
Lei Guo and colleagues demonstrated in Rescuing macrophage normal function in spinal cord injury with embryonic stem cell conditioned media that embryonic stem cell conditioned media can "reboot" macrophages that have become dysfunctional after consuming myelin debris. This "cell-free" approach is echoed in work by Xianli Wu and Zhe Jin, who highlight in Exosome-mediated effects and applications in inflammatory diseases of the digestive system how MSC-derived exosomes act as membrane-bound "mail carriers" that reprogram macrophages to resolve inflammation in the gut.
Molecular Brakes and Metabolic Switches
To precisely control this switch, researchers are identifying the specific molecular "brakes" that lock cells in an inflammatory state.
- Genetic Regulators: In Adipose-Derived Mesenchymal Stem Cells Accelerate Diabetic Foot Ulcer Healing by Promoting Macrophage M2 Polarization Through Downregulation of EREG and CSTA, Jing Cao and Wenqiang An identified a two-gene signature (EREG and CSTA) that prevents healing in diabetic ulcers. Downregulating these genes allows the local environment to transition to a regenerative M2 state.
- Metabolic Pathways: Autophagy, the cell's internal cleaning mechanism, has emerged as a critical regulator. The study Ginseng exosomes modulate M1/M2 polarisation by activating autophagy and target IKK/IкB/NF-кB to alleviate inflammatory bowel disease suggests that inducing cellular self-cleaning can actively resolve chronic inflammation rather than merely suppressing it.
- Efferocytosis: The process of clearing dead cells (efferocytosis) is itself a pro-healing signal. Lu Sun and Zehang Liang showed in Enucleated bone marrow-derived mesenchymal stromal cells regulate immune microenvironment and promote testosterone production through efferocytosis that even enucleated "Cargocytes" can trigger this pathway, shifting macrophages to an M2 phenotype to restore hormonal function.
Resolving Chronic Rejection and Fibrosis
This paradigm is also transforming organ transplantation and fibrosis research. Instead of broad immunosuppression, which leaves patients vulnerable to infection, researchers are looking for ways to induce "immune tolerance."
Gangcheng Kong and Huadong Li found that by inhibiting miR-155, they could activate the SOCS5 protein, shifting macrophages to a pro-repair state and significantly reducing chronic heart transplant rejection (Adenovirus-IL-10 relieves chronic rejection after mouse heart transplantation by inhibiting miR-155 and activating SOCS5). By focusing on the mode of macrophage death and the resulting signals, as explored by Jun Hou in Macrophage regulated cell death: implications and mechanisms in organ transplantation, clinicians may eventually be able to "train" the immune system to accept a graft as "self" rather than "other."